S1441
Interdisciplinary - Other
ESTRO 2026
and potential to improve patient selection and safety oversight. Prospective implementation and systematic documentation will be essential to inform future clinical guidelines, ensure reproducibility, and define the therapeutic role of cardiac radiotherapy in advanced cardiac disease management. Keywords: Cardiac radiotherapy, standardized reporting
Based on data extraction from August 2025, 12 of 17 Swedish RT departments (71%) are connected to SKvaRT. The registry contained data from 52,437 patients and 59,473 treatments covering the period 2016–2024 (Figure 1). National completeness for 2024 was estimated to 40–42% but exceeded 80% for five of
nine RT departments that had reported data consistently over longer periods (Table1).
Digital Poster 1836
Promising coverage and completeness of the new Swedish national quality registry for radiotherapy Caroline E Olsson 1,2 , David B Norman 3 , Josef A Lundman 4 , Magnus G Karlsson 4 1 Medical Radiation Science, Clinical Sciences/Sahlgrenska Academy/Gothenburg University, Gothenburg, Sweden. 2 Regional Cancer Center West, Region Västra Götaland, Gothenburg, Sweden. 3 Regional Cancer Center North, Region Västerbotten, Umeå, Sweden. 4 Diagnostics and Intervention, Umeå University, Umeå, Sweden Purpose/Objective: The Swedish national quality registry for radiotherapy (RT; In Swedish:Svenska Kvalitetsregistret för RadioTerapi [SKvaRT]) was launched in 2023. Its primary purpose is to highlight temporal variations in RT, improve adherence to national treatment guidelines, and provide data for healthcare development, quality monitoring, clinical audit, and research. The aim of this study is to report results from 2024, the most recent summary orchestrated by SKvaRT’s steering committee. Material/Methods: SKvaRT is a methodological registry for RT that stores information on delivered treatments since 2016 for all cancer diagnoses. Data are automatically retrieved from hospital information systems via local database solutions (MIQA1) and transferred in a standardized format to SKvaRT. The SKvaRT steering committee, comprising representatives (primarily oncologists and medical physicists) from all six Swedish healthcare regions and adjunct members from the Swedish Radiation Safety Authority and academia, oversees variable selection, reporting of results, and research initiatives. Comprehensive quality assurance is conducted when a hospital connects to the registry for the first time, and MIQA also provides built-in monitoring functions that contribute to high data quality. Descriptive statistics for 2024 include number of RT departments reporting to SKvaRT and the completeness in relation to reference national data on number of patients and treatments for this same period. Results:
Figure 1. Total number of patients (solid line) and treatments (dotted line) reported into SKvaRT between 2023 to 2024.Table 1. Completeness for nine of the 17 Swedish RT departments that report data into SKvaRT since its launching year in 2023
Conclusion: This study demonstrates promising results in both coverage and completeness of RT data in SKvaRT, the new Swedish national quality registry for radiotherapy. By its second operating year, almost three of four RT departments can technically report data into SKvaRT and up to 93% coverage could be noted for one of the long-term reporting sites. References: 1Nyholm et al. A national approach for automated collection of standardized and population-based radiation therapy data in Sweden. Radiother Oncol. 2016 May;119(2):344-50.NOTE: This work is submitted on behalf of the SKvaRT steering committee. Keywords: radiotherapy register
Digital Poster 1877 Systematic review of disease-agnostic technical requirements in phase 3 SBRT/SABR trials
Made with FlippingBook - Share PDF online